Infectious Disease Institute

 Staphylococcus aureus leads to caspase-1 activation in primary conjunctival goblet cells.

Michael S. Gilmore, PhD

James Chodosh, MD, MPH
Marlene Durand, MD

See a list of Infectious Disease faculty


The Infectious Disease Institute is a Harvard-wide initiative that operates in conjunction with the NIH-sponsored Harvard-wide Program on Antibiotic Resistance/Boston Area Antibiotic Resistance Network. This alliance promotes interdisciplinary collaboration between Harvard affiliate hospitals and industry partners to screen and validate new compounds and for microbial infections—many of which can affect the eye. Members of the Infectious Disease Institute also explore the cellular mechanisms of infection (including host-pathogen interactions) and the genetics of microbial pathogens (such as viruses, bacteria, and fungi) to identify novel therapeutic targets.

Image: Staphylococcus aureus leads to caspase-1 activation in primary conjunctival goblet cells. From: McGilligan VE et al. PLoS One. 2013 Sep 10;8(9):e74010. 

Featured News

michael gilmore

Mass. Eye and Ear team discovers, successfully treats new variant of antibiotic-resistant bacterium

September 15, 2016

Boston, Mass. —  Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by inhibiting white blood cells that ordinarily kill and remove bacteria.